Therapeutic factors considered according to the preoperative splenic volume for a prolonged increase in platelet count after partial splenic embolization for liver cirrhosis

被引:29
作者
Hayashi, Hiromitsu [1 ]
Beppu, Toru [1 ]
Okabe, Kazutoshi [2 ]
Masuda, Toshiro [1 ]
Okabe, Hirohisa [1 ]
Ishiko, Takatoshi [1 ]
Baba, Hideo [1 ]
机构
[1] Kumamoto Univ, Grad Sch Med Sci, Dept Surg Gastroenterol, Kumamoto 8608556, Japan
[2] NTT W Japan Kyushu Hosp, Dept Surg, Kumamoto 8628655, Japan
关键词
Partial splenic embolization; Liver cirrhosis; Infarcted splenic volume; Noninfarcted splenic volume; Splenic infarction ratio; ARTERIAL EMBOLIZATION; HYPERSPLENISM; INFECTION; RIBAVIRIN; PEGINTERFERON; TELAPREVIR;
D O I
10.1007/s00535-009-0185-9
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Infarcted splenic volume has been identified as the predictive factor for a prolonged increase in platelet count after partial splenic embolization (PSE). However, despite enough infarcted splenic volume, some patients show only a slight increase in platelet counts after PSE because of rapid regrowth of the noninfarcted splenic parenchyma within several months post-PSE. The purpose of this study was to determine the therapeutic factors based on the preoperative splenic volume for a prolonged increase in platelet counts after PSE. In 72 cirrhotic patients with follow-ups longer than 1 year post-PSE, depending on the preoperative splenic volume, the splenic factors associated with a prolonged increase in platelet counts at 1 year after PSE were retrospectively examined. In 57 patients with preoperative splenic volumes a parts per thousand currency sign700 ml, the preoperative splenic volume (P = 0.001), infarcted splenic volume (P < 0.001), and splenic infarction ratio (P = 0.001) showed positive correlations with increments in platelet counts at 1 year post-PSE. In 15 patients with preoperative splenic volumes > 700 ml, noninfarcted splenic volume (P = 0.003) and splenic infarction ratio (P = 0.002) showed negative and positive correlations with the increment in platelet counts at 1 year post-PSE, respectively. In patients with splenic volumes a parts per thousand currency sign700 ml, the infarcted splenic area significantly affects the prolonged increase in platelet counts post-PSE. In patients with splenic volumes > 700 ml, the noninfarcted splenic area is significant.
引用
收藏
页码:554 / 559
页数:6
相关论文
共 15 条
[1]   EVALUATION OF SPLENIC EMBOLIZATION IN PATIENTS WITH PORTAL-HYPERTENSION AND HYPERSPLENISM [J].
ALWMARK, A ;
BENGMARK, S ;
GULLSTRAND, P ;
JOELSSON, B ;
LUNDERQUIST, A ;
OWMAN, T .
ANNALS OF SURGERY, 1982, 196 (05) :518-524
[2]   Safe use of pegylated interferon/ribavirin in hepatitis C virus cirrhotic patients with hypersplenism after partial splenic embolization [J].
Foruny, JR ;
Blázquez, J ;
Moreno, A ;
Bárcena, R ;
Gil-Grande, L ;
Quereda, C ;
Pérez-Elías, MJ ;
Moreno, J ;
Sánchez, J ;
Muriel, A ;
Rodriguez-Sagrado, MA ;
Moreno, S .
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2005, 17 (11) :1157-1164
[3]   Risk factors for complications after partial splenic embolization for liver cirrhosis [J].
Hayashi, H. ;
Beppu, T. ;
Okabe, K. ;
Masuda, T. ;
Okabe, H. ;
Baba, H. .
BRITISH JOURNAL OF SURGERY, 2008, 95 (06) :744-750
[4]   Predictive factors for platelet increase after partial splenic embolization in liver cirrhosis patients [J].
Hayashi, Hiromitsu ;
Beppu, Toru ;
Masuda, Toshiro ;
Mizumoto, Takao ;
Takahashi, Masashi ;
Ishiko, Takatoshi ;
Takamori, Hiroshi ;
Kanemitsu, Keiichiro ;
Hirota, Masahiko ;
Baba, Hideo .
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2007, 22 (10) :1638-1642
[5]   Telaprevir and Peginterferon with or without Ribavirin for Chronic HCV Infection [J].
Hezode, Christophe ;
Forestier, Nicole ;
Dusheiko, Geoffrey ;
Ferenci, Peter ;
Pol, Stanislas ;
Goeser, Tobias ;
Bronowicki, Jean-Pierre ;
Bourliere, Marc ;
Gharakhanian, Shahin ;
Bengtsson, Leif ;
McNair, Lindsay ;
George, Shelley ;
Kieffer, Tara ;
Kwong, Ann ;
Kauffman, Robert S. ;
Alam, John ;
Pawlotsky, Jean-Michel ;
Zeuzem, Stefan .
NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (18) :1839-1850
[6]  
HIRAI K, 1986, HEPATO-GASTROENTEROL, V33, P105
[7]   Telaprevir with Peginterferon and Ribavirin for Chronic HCV Genotype 1 Infection [J].
McHutchison, John G. ;
Everson, Gregory T. ;
Gordon, Stuart C. ;
Jacobson, Ira M. ;
Sulkowski, Mark ;
Kauffman, Robert ;
McNair, Lindsay ;
Alam, John ;
Muir, Andrew J. .
NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (18) :1827-1838
[8]  
MOZES MF, 1984, SURGERY, V96, P694
[9]   Partial splenic embolization in patients with cirrhosis: efficacy, tolerance and long-term outcome in 32 patients [J].
N'Kontchou, G ;
Seror, O ;
Bourcier, V ;
Mohand, D ;
Ajavon, Y ;
Castera, L ;
Grando-Lemaire, V ;
Ganne-Carrie, N ;
Sellier, N ;
Trinchet, JC ;
Beaugrand, M .
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2005, 17 (02) :179-184
[10]   Changes in platelet kinetics after a partial splenic arterial embolization in cirrhotic patients with hypersplenism [J].
Noguchi, H ;
Hirai, K ;
Aoki, Y ;
Sakata, K ;
Tanikawa, K .
HEPATOLOGY, 1995, 22 (06) :1682-1688